Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection

A Randomized, Double-blind, Parallel, Placebo-controlled Study for the Assessment of the Safety and Efficacy of BTL-TML-HSV for the Treatment of Recurrent Symptomatic Oral Herpes Virus Infection

The purpose of this study is to determine if a new treatment is effective for the treatment of recurrent symptomatic oral herpes virus infections.

Inclusion Criteria:

• Clinical history of recurrent cold sores averaging 2 or more episodes per year
• Experiences prodromal symptoms (tingling, burning, itching) of cold sores
• Herpes Simplex Virus seropositive (by blood test)

Exclusion Criteria:

• Immuno-suppressed or taking immunosuppressant medication
• Use of antiviral therapy directly prior and during the study